MIG
IBB icon

McGuire Investment Group’s iShares Biotechnology ETF IBB Stock Holding History

McGuire Investment Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-59,752
Closed -$7.64M – 115
2025
Q1 		$7.64M Sell
59,752
-7,600
-11% -$1.03M 1.14% 34
2024
Q4 		$8.9M Sell
67,352
-3
-0% -$422 1.29% 32
2024
Q3 		$9.81M Sell
67,355
-366
-0.5% -$53K 1.38% 28
2024
Q2 		$9.3M Buy
67,721
+232
+0.3% +$31K 1.33% 28
2024
Q1 		$9.26M Buy
67,489
+541
+0.8% +$73.9K 1.35% 27
2023
Q4 		$9.09M Buy
66,948
+3,326
+5% +$406K 1.52% 22
2023
Q3 		$7.78M Buy
63,622
+1,489
+2% +$189K 1.5% 26
2023
Q2 		$7.89M Sell
62,133
-957
-2% -$124K 1.47% 25
2023
Q1 		$8.15M Sell
63,090
-3,725
-6% -$488K 1.62% 25
2022
Q4 		$8.77M Buy
66,815
+5,836
+10% +$754K 1.9% 21
2022
Q3 		$7.13M Sell
60,979
-38
-0.1% -$4.72K 1.62% 27
2022
Q2 		$7.18M Sell
61,017
-1,861
-3% -$221K 1.55% 28
2022
Q1 		$8.19M Buy
62,878
+2,159
+4% +$281K 1.5% 27
2021
Q4 		$9.27M Sell
60,719
-5,630
-8% -$872K 1.53% 25
2021
Q3 		$10.7M Buy
66,349
+309
+0.5% +$52K 2.02% 18
2021
Q2 		$10.8M Buy
66,040
+1,616
+3% +$249K 2.05% 15
2021
Q1 		$9.7M Buy
64,424
+28,346
+79% +$4.5M 2.05% 18
2020
Q4 		$5.46M Buy
36,078
+796
+2% +$114K 1.35% 29
2020
Q3 		$4.78M Buy
35,282
+493
+1% +$66.9K 1.42% 28
2020
Q2 		$4.75M Buy
34,789
+236
+0.7% +$30.1K 1.65% 23
2020
Q1 		$3.72M Sell
34,553
-574
-2% -$66.1K 1.55% 23
2019
Q4 		$4.23M Sell
35,127
-251
-0.7% -$28K 1.26% 32
2019
Q3 		$3.52M Sell
35,378
-138
-0.4% -$14.4K 1.15% 35
2019
Q2 		$3.88M Sell
35,516
-323
-0.9% -$34.4K 1.23% 33
2019
Q1 		$4.01M Buy
35,839
+250
+0.7% +$27.4K 1.31% 30
2018
Q4 		$3.43M Buy
35,589
+180
+0.5% +$19.1K 1.3% 29
2018
Q3 		$4.32M Buy
+35,409
New +$4.17M 1.43% 29

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

McGuire Investment Group's IBB Position: Q2 2025 in Review

McGuire Investment Group sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 59,752 shares — an estimated $7.64M sold.

McGuire Investment Group first reported a position in IBB in Q3 2018 and held it in 27 quarters. The position peaked at $10.8M in Q2 2021. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • McGuire Investment Group reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • McGuire Investment Group sold 59,752 iShares Biotechnology ETF shares in Q2 2025, an estimated $7.64M.
  • McGuire Investment Group first reported a position in iShares Biotechnology ETF in Q3 2018 and held it in 27 quarters.
  • McGuire Investment Group's iShares Biotechnology ETF position peaked at $10.8M in Q2 2021.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on McGuire Investment Group's 13F filing for Q2 2025, filed 18 Jul 2025.